PLA2R and THSD7A: Disparate Paths to the Same Disease?

Area of Science:

• Nephrology
• Immunology
• Molecular Biology

Background:

• Primary membranous nephropathy (MN) is classified into subclasses based on two major autoantigens: phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A).
• Both PLA2R and THSD7A are podocyte-expressed transmembrane glycoproteins that elicit IgG4-predominant autoantibody responses.
• These autoantibodies are valuable for clinical diagnosis and monitoring of MN.

Purpose of the Study:

• To review the current understanding of PLA2R and THSD7A as key autoantigens in primary MN.
• To discuss the molecular subclasses, diagnostic implications, and potential biological roles of these autoantigens.
• To explore genetic associations and future directions for identifying novel autoantigens in MN.

Main Methods:

• Review of existing literature on PLA2R and THSD7A in primary membranous nephropathy.
• Analysis of genetic associations, including HLA loci.
• Discussion of diagnostic utility of autoantibodies and potential novel identification techniques.

Main Results:

• PLA2R and THSD7A define distinct molecular subclasses of primary MN.
• Circulating autoantibodies against PLA2R and THSD7A are clinically relevant for diagnosis and monitoring.
• PLA2R-associated MN shows genetic links to HLA loci, while THSD7A-associated MN may correlate with malignancy.

Conclusions:

• PLA2R and THSD7A are the primary targets in MN, with distinct clinical and genetic associations.
• Further research into the biological functions of these autoantigens is warranted.
• Advanced techniques may facilitate the discovery of additional autoantigens in primary MN.